{
    "id": 3101,
    "fullName": "EGFR G721D",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "EGFR G721D lies within the protein kinase domain of the Egfr protein (UniProt.org). G721D is predicted to be activating by structural modeling (PMID: 24817905), but has not been biochemically characterized and therefore, its effect on Egfr protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 1876,
                    "pubMedId": 24817905,
                    "title": "Structure-functional prediction and analysis of cancer mutation effects in protein kinases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24817905"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "G721D",
    "createDate": "02/12/2015",
    "updateDate": "10/31/2019",
    "referenceTranscriptCoordinates": {
        "id": 135659,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55174021G>A",
        "cDna": "c.2162G>A",
        "protein": "p.G721D",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17650,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, Iressa (gefitinib) treatment resulted in a partial response with a progression-free survival of 13 months in a patient with non-small cell lung cancer harboring both EGFR G721D and EGFR E746_A750del (PMID: 31175009).",
            "molecularProfile": {
                "id": 32731,
                "profileName": "EGFR G721D EGFR E746_A750del"
            },
            "therapy": {
                "id": 751,
                "therapyName": "Gefitinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15702,
                    "pubMedId": 31175009,
                    "title": "Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31175009"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2924,
            "profileName": "EGFR G721D",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 32731,
            "profileName": "EGFR G721D EGFR E746_A750del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 135659,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55174021G>A",
            "cDna": "c.2162G>A",
            "protein": "p.G721D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}